Drug class
Oxazolobenzodiazepine anxiolytic; positive allosteric modulator of GABAA receptors
Mechanism of action
Binds to the benzodiazepine site on GABAA receptor complexes and enhances the effect of endogenous GABA, increasing chloride-channel opening and neuronal inhibition, thereby producing anxiolytic and sedative effects.
General use cases
- Treatment of anxiety disorders, with or without associated psychoneurotic conditions, in countries where mexazolam is authorised.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
